Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Biliary atresia (BA) is a rare cholangiopathy where one of the proposed aetiological mechanisms is an infectious viral trigger. Coronavirus disease-19 (COVID) lockdown restrictions were implemented to reduce the transmission of infections. Strictness of lockdown varied across European countries. This study aimed to investigate if there was an association between strictness of lockdown and change in isolated BA (IBA) incidence in Europe.

Methods: We approached European centres involved in the European Reference Network RARE-LIVER. We included IBA patients born between 2015 and June 2020. We calculated the number of IBA patients born per centre per month. The Stringency Index (SI) was used as lockdown strictness indicator. The association between percentage change of mean number of IBA patients born per month and the SI was assessed.

Results: We included 412 IBA patients from thirteen different centres. The median number of patients per month did not change: 6 (1-15) pre-lockdown and 7 (6-9) during lockdown ( = 0.34). There was an inverse association between SI and percentage change in IBA (B = -0.73, = 0.03). Median age at Kasai portoenterostomy (days) did not differ between time periods (51 (9-179) vs. 53 (19-126), = 0.73).

Conclusion: In this European study, a stricter COVID-lockdown was seemingly accompanied by a simultaneous larger decrease in the number of IBA patients born per month in the lockdown. Results should be interpreted with caution due to the assumptions and limitations of the analysis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918263PMC
http://dx.doi.org/10.3390/jcm12030775DOI Listing

Publication Analysis

Top Keywords

iba patients
20
patients born
16
number iba
12
biliary atresia
8
covid lockdown
8
strictness lockdown
8
association percentage
8
percentage change
8
born month
8
lockdown
7

Similar Publications

Alzheimer's disease (AD) is marked by amyloid-beta (Aβ) plaque buildup, tau hyperphosphorylation, neuroinflammation, neuronal loss, and impaired adult hippocampal neurogenesis (AHN). Taurine has shown protective effects in various cellular and animal models of AD, though the molecular mechanisms of free taurine and its effects in patient-derived models remain underexplored. This study evaluates taurine's therapeutic potential using integrated in silico, in vitro, in vivo, and ex vivo approaches.

View Article and Find Full Text PDF

Although the recently approved prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) [Lu]Lu-PSMA-617 has improved outcomes for patients with metastatic castration-resistant prostate cancer (mCRPC), not all patients respond optimally to this treatment; even measuring response accurately can be difficult. Moreover, there is currently a lack of validated prognostic and predictive biomarkers for [Lu]Lu-PSMA-617 treatment in this patient population. There is, therefore, a growing need to identify biomarkers to help optimize patient selection for [Lu]Lu-PSMA-617 and guide therapy decision-making.

View Article and Find Full Text PDF

Background And Purpose: Reducing the dose rate enhances efficacy in radiation therapy by allowing increased repair of sub-lethal damage. Pulsed low-dose radiation therapy (PLDR) is an innovative approach that is safe and effective for the reirradiation of recurrent gliomas and radioresistant tumors. In this study, the accuracy of the low dose rate volumetric modulated arc therapy (VMAT) delivery is tested in an Elekta Versa HD linear accelerator (linac) for delivering PLDR.

View Article and Find Full Text PDF

Background: Parkinson's disease (PD), the most prevalent neurodegenerative disorder, affects over 7.5 million individuals worldwide and imposes a substantial financial burden. Exercise (EXE) has demonstrated efficacy in improving motor symptoms of PD; however, its application is limited by motor symptoms such as bradykinesia, rigidity, gait instability, and fatigue, which reduce patient tolerance and adherence.

View Article and Find Full Text PDF

FLASH-enabled Proton SBRT for a challenging case of spine metastasis.

Phys Med Biol

September 2025

Department of oncology, Laboratory of Experimental Radiotherapy, KU Leuven, Herestraat 49, Leuven, Vlaanderen, 3001, BELGIUM.

Objective: The FLASH effect, characterized by potential sparing of organs at risk (OAR) through ultra-high dose rate irradiation, has garnered significant attention for its capability to address indications previously untreatable at conventional dose rates (DR) with hypofractionated schemes. While considerable biological research is needed to understand the FLASH effect and determine the FLASH modifying factors (FMF) for individual OARs, treatment planning studies have also emerged. This study evaluates the feasibility of achieving FLASH conditions in proton stereotactic body radiotherapy for spine metastases and establishes the required FMFs under different fractionation regimens.

View Article and Find Full Text PDF